SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001399529-21-000074
Filing Date
2021-04-20
Accepted
2021-04-20 16:26:51
Documents
6
Period of Report
2021-06-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A drna_2021xdef14a.htm DEF 14A 1011977
2 dicernapharmaceuticalsinc_.jpg GRAPHIC 372801
3 dicernapharmaceuticalsinc_a.jpg GRAPHIC 350607
4 dicernareports1q191.jpg GRAPHIC 22788
5 image1.jpg GRAPHIC 26048
6 image1a031.gif GRAPHIC 7267
  Complete submission text file 0001399529-21-000074.txt   2087265
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36281 | Film No.: 21838179
SIC: 2834 Pharmaceutical Preparations